. 2020 Oct;8(20):1292. doi: 10.21037/atm-20-5525

Table 3. Impact of treatment on overall survival in patients with resected SCLC with T1N0M0 status.

Treatment group	Univariate analysis			P_trend^a	Multivariate analysis			P_trend^b
Treatment group	HR	95% CI	P^a	P_trend^a	HR	95% CI	P^b	P_trend^b
Sublobectomy	Reference			0.011	Reference			0.047
Lobectomy	1.060	0.641–1.752	0.822		1.095	0.662–1.811	0.725
Sublob + chemo/radio	1.274	0.664–2.443	0.467		1.304	0.680–2.501	0.425
Lob + chemo/radio	0.750	0.439–1.282	0.293		0.851	0.494–1.465	0.561
Sublob + chemo + radio	1.049	0.480–2.293	0.904		1.220	0.554–2.687	0.621
Lob + chemo + radio	0.377	0.189–0.754	0.006		0.438	0.217–0.882	0.021

^a, univariate Cox analysis; ^b, multivariate Cox analysis. SCLC, small cell lung cancer; HR, hazard ratio; CI, confidence interval; sublob + chemo/radio, sublobectomy + chemotherapy/radiotherapy; lob + chemo/radio, lobectomy + chemotherapy/radiotherapy; sublob + chemo + radio, sublobectomy + chemotherapy + radiotherapy; lob + chemo + radio, lobectomy + chemotherapy + radiotherapy.